Page last updated: 2024-12-07

3-(2-(2-aminoethyl)ethylamino)propyltrimethoxysilane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(2-(2-aminoethyl)ethylamino)propyltrimethoxysilane: silylating reagent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID118771
CHEMBL ID3561898
SCHEMBL ID37873
MeSH IDM0286354

Synonyms (54)

Synonym
n1-(3-trimethoxysilylpropyl)diethylenetriamine, technical grade
diethylenetriaminopropyltrimethoxysilane
n'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine
35141-30-1
3w3e2d4706 ,
einecs 252-390-9
unii-3w3e2d4706
1,2-ethanediamine, n1-(2-aminoethyl)-n2-(3-(trimethoxysilyl)propyl)-
1,2-ethanediamine, n-(2-aminoethyl)-n'-(3-(trimethoxysilyl)propyl)-
(3-trimethoxysilylpropyl)diethylenetriamine
3-(2-(2-aminoethyl)ethylamino)propyltrimethoxysilane
n-(2-aminoethyl)-n'-(3-(trimethoxysilyl)propyl)ethylenediamine
(3-(trimethoxysilyl)propyl)diethylenetriamine
1,2-ethanediamine, n-(2-aminoethyl)-n'-[3-(trimethoxysilyl)propyl]-
S18300
AKOS015901807
3-[2-(2-aminoethylamino)ethylamino]propyl-trimethoxysilane
3-[2-(2-aminoethylamino)ethylamino]propyltrimethoxysilane
n1-(3-trimethoxysilylpropyl)diethylenetriamine
2-[2-(3-trimethoxysilylpropylamino)ethylamino]ethylamine
3-trimethoxysilylpropyldiethylenetriamine
SCHEMBL37873
n1-(2-aminoethyl)-n2-(3-(trimethoxysilyl)propyl)ethane-1,2-diamine
dtxsid2044422 ,
n-(2-aminoethyl)-n'-[3-(trimethoxysilyl)propyl]ethane-1,2-diamine
n'-(2-(3-trimethoxysilylpropylamino)ethyl)ethane-1,2-diamine
10-trimethoxysilyl-1,4,7-triazadecan
(2-((2-aminoethyl)amino)ethyl)(3-(trimethoxysilyl)propyl)amine
trimethoxy silylpropyldiethylenetriamine
n-3-(trimethoxysilyl)propyl)diethylenetriamine
n-(2-aminoethyl)-n'-(3-(trimethoxysilyl)propyl)ethane-1,2-diamine
dynasylan triamo
trimethoxy(9-amino-4,7-diazanonane-1-yl)silane
4,7,10-triazadecyltrimethoxysilane
(3-(2-(2-(2-aminoethylamino)ethyl)amino)propyl)trimethoxysilane
NCGC00357015-01
tox21_303768
n-(2-aminoethyl)-n'-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
j289.914k ,
1-(3-(trimethoxysilyl)propyl)diethylenetriamine
cas-35141-30-1
3-diethylenetriaminopropyltrimethoxysilane
dtxcid0024422
CHEMBL3561898
mfcd00069173
J-019958
trimethoxysilylpropyldiethylenetriamine
FT-0752427
n-[3-(trimethoxysilyl)propyl]diethylenetriamine
3-[2-(2-aminoethylamino)-ethylamino]-propyl trimethoxysilane
Q27258112
CS-0451534
2-[2-(3-trimethoxysilylpropylami)ethylami]ethylamine
F71294
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency68.58960.000714.592883.7951AID1259392
AR proteinHomo sapiens (human)Potency15.35530.000221.22318,912.5098AID1259381
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.58960.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency52.13240.001530.607315,848.9004AID1224841; AID1259401
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]